ITGA2 and colorectal cancer: Augmentation of CD4+ T cells, CD8+ T cells and CD49b+ NK cells, as well as increased expressions of IFNg, IL10, CXCR4, and reduced expressions of IL17, STAT3 screened from gene and protein levels, jointly create a microenvironment conducive to inhibit the progress of colorectal cancer.